Carey Dobbins Sood, MD
Obstetrics & Gynecology · Marietta, GANPI 1336326958
Payments from drug & device makers
Across 122 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$506
- Evofem Biosciences, Inc.$407
- Astellas Pharma US Inc$269
- Pfizer$170
- Bayer$153
- Duchesnay USA Incorporated$125
- plus $641 from 14 others
What the payments were for
- Food & beverage$2,24699%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $506 |
| Evofem Biosciences, Inc. | 24 | $407 |
| Astellas Pharma US Inc | 11 | $269 |
| Pfizer | 9 | $170 |
| Bayer | 8 | $153 |
| Duchesnay USA Incorporated | 7 | $125 |
| Mayne Pharma Commercial LLC | 5 | $103 |
| Hologic Sales And Service, LLC | 4 | $81 |
| Organon | 5 | $78 |
| Optumhealth Care Solutions, LLC | 3 | $65 |
| Sumitomo Pharma America, Inc. | 3 | $62 |
| Therapeuticsmd, Inc. | 3 | $47 |
| Smith+Nephew | 2 | $38 |
| Millicent US Inc | 2 | $35 |
| Lupin Inc. | 2 | $33 |
| Mylan Pharmaceuticals Inc. | 2 | $30 |
| Meditrina | 2 | $23 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Aspira Women's Health Inc | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,270 in reported general payments places this provider in the 70th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 102 | $5,439 |
| Estradiol (Twice Weekly)Estradiol | 18 | $1,242 |
| Medroxyprogesterone Acetate | 22 | $569 |
| Norethindrone Acetate | 12 | $562 |
| Clobetasol Propionate | 16 | $557 |
| Metronidazole | 14 | $206 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $105 |
| Fluconazole | 19 | $74 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Marietta
- David MontaldiMarietta$1.1M
- Teresa ByrdMarietta$41K
- Eduardo EstrellaMarietta$26K
- Jeffrey MarcusMarietta$12K
- Gretchen MitchellCumming$4.5M
- Stephen BlankAtlanta$3.5M
- Eric BrownAtlanta$1.7M
- Melissa KottkeAtlanta$1.7M
- Allan DinnersteinFort Stewart$1.5M
- Winifred SoufiAtlanta$889K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.